AstraZeneca to buy Alexion for $39 billion to expand in immunology
Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.
via pk48jobsMarkets
https://foxbusiness.com/markets/astrazeneca-to-buy-alexion-for-39-billion-to-expand-in-immunology
0 Comments
If you have any doubts , Please let me now
Emoji